These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 17332363)
1. Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Javelaud D; Mohammad KS; McKenna CR; Fournier P; Luciani F; Niewolna M; André J; Delmas V; Larue L; Guise TA; Mauviel A Cancer Res; 2007 Mar; 67(5):2317-24. PubMed ID: 17332363 [TBL] [Abstract][Full Text] [Related]
2. TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases. Mohammad KS; Javelaud D; Fournier PG; Niewolna M; McKenna CR; Peng XH; Duong V; Dunn LK; Mauviel A; Guise TA Cancer Res; 2011 Jan; 71(1):175-84. PubMed ID: 21084275 [TBL] [Abstract][Full Text] [Related]
4. Halofuginone inhibits the establishment and progression of melanoma bone metastases. Juárez P; Mohammad KS; Yin JJ; Fournier PG; McKenna RC; Davis HW; Peng XH; Niewolna M; Javelaud D; Chirgwin JM; Mauviel A; Guise TA Cancer Res; 2012 Dec; 72(23):6247-56. PubMed ID: 23002206 [TBL] [Abstract][Full Text] [Related]
5. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo. Javelaud D; Delmas V; Möller M; Sextius P; André J; Menashi S; Larue L; Mauviel A Oncogene; 2005 Nov; 24(51):7624-9. PubMed ID: 16007121 [TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related protein and bone metastases. Guise TA Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. Kakonen SM; Selander KS; Chirgwin JM; Yin JJ; Burns S; Rankin WA; Grubbs BG; Dallas M; Cui Y; Guise TA J Biol Chem; 2002 Jul; 277(27):24571-8. PubMed ID: 11964407 [TBL] [Abstract][Full Text] [Related]
8. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. Yin JJ; Selander K; Chirgwin JM; Dallas M; Grubbs BG; Wieser R; Massagué J; Mundy GR; Guise TA J Clin Invest; 1999 Jan; 103(2):197-206. PubMed ID: 9916131 [TBL] [Abstract][Full Text] [Related]
13. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression. Javelaud D; van Kempen L; Alexaki VI; Le Scolan E; Luo K; Mauviel A Mol Cancer; 2011 Jan; 10(1):2. PubMed ID: 21211030 [TBL] [Abstract][Full Text] [Related]
14. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Johnson RW; Nguyen MP; Padalecki SS; Grubbs BG; Merkel AR; Oyajobi BO; Matrisian LM; Mundy GR; Sterling JA Cancer Res; 2011 Feb; 71(3):822-31. PubMed ID: 21189326 [TBL] [Abstract][Full Text] [Related]
15. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer. Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619 [TBL] [Abstract][Full Text] [Related]
16. Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo. Luwor RB; Baradaran B; Taylor LE; Iaria J; Nheu TV; Amiry N; Hovens CM; Wang B; Kaye AH; Zhu HJ Oncogene; 2013 May; 32(19):2433-41. PubMed ID: 22751114 [TBL] [Abstract][Full Text] [Related]
17. A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression. Cheng JN; Frye JB; Whitman SA; Kunihiro AG; Pandey R; Funk JL Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923316 [TBL] [Abstract][Full Text] [Related]